Morria's drug pipeline is based on innovative anti-inflammatory technology developed at Hebrew University and commercialized through Yissum Technology Transfer Company.

Method enables accurate identification of a suspect's DNA in crime scenes even when DNA evidence comprises a mixture from multiple individuals

El estado hebreo, el país con más ingenieros por kilómetro cuadrado, espera cerrar 2010 con un crecimiento del 4,1% pese al permanente conflicto con sus vecinos y la crisis mundial

Innovative medicinal application developed by Hebrew U. scientists fights gum diseases in kangaroos. The animal application has been patented by Yissum - the Hebrew University's technology transfer company – and is being offered for commercialization.

Yissum presents new business approaches at Canadian conference “Creating Jobs in the Knowledge Economy”.

Israel has 12 technology transfer organizations, seven of them university-based and five in its leading research hospitals. They are highly effective: the Hebrew University's Yissum, for example, founded in 1964, generates more revenue than its counterparts at MIT, Harvard or NYU in its management and licensing of thousands of patents developed within the institution.

Researchers at the Hebrew University of Jerusalem have discovered a group of substances in the body that play a key role in controlling bone density, and on this basis they have begun development of a drug for prevention and treatment of osteoporosis and other bone disorders.

The Wall Street Journal wrote, “Surveillance cameras generate a prodigious amount of video; unfortunately there's not enough time and manpower to watch it all.

Yissum, l’organisation de transfert de technologie attachée à l’université hébraïque de Jérusalem, a lancé en juin ernier sa nouvelle plate-forme de calcul. Elle vise à accélérer la découverte de molécules thérapeutiques.

The trial is designed to evaluate the safety, tolerability and pharmacokinetics of AB103. It is a double blind, placebo controlled study that includes up to 38 healthy volunteers receiving escalating single doses of AB103, with one group receiving multiple doses. The study is being conducted at the University of Maryland in Baltimore.

Hebrew U. goes global – thanks to accredited online courses with eTeacher

The researchers registered a patent this year on their therapy through Yissum, the Hebrew University's technology transfer body. Yissum is now seeking a commercial partner to continue developing the treatment ahead of the next phase of experimentation, on animals, and later, if its efficacy is proven, on humans.

Professors Abraham Loyter and Assaf Friedler at The Hebrew University of Jerusaleman present and innovative approach to eliminate HIV in host by targeted killing of only HIV infected cells. This approach if successful could lead into an anti-HIV therapy that will eradicate the virus.

Using GPS technology, Israeli scientists can track our activities in space and time, spurring a seemingly infinite number of potential applications from medicine to crowd control.

Teo Sanchez, energy technology and policy advisor at Practical Action, a charity which promotes technology for development, said: "With half the world's population having no access to modern energy, this research is a valuable contribution to one of the biggest challenges in the world".

An electric battery based on boiled potatoes could provide a cheap source of electricity in the developing world, according to the technology transfer company of the Hebrew University of Jerusalem.

Morria Biopharmaceuticals Plc, a biopharmaceutical company focused on novel, anti-inflammatory drugs, announced today that it will be presenting the results from its ICH compliant Phase II study of MRX-4 (n=105) in patients suffering from allergic rhinitis at the upcoming 29th EAACI Congress (European Academy of Allergy and Clinical Immunology) in London on June 7th.

The eight Israeli companies are attracTV, BriefCam Ltd., MS Tech Ltd., SolarEdge Technologies Ltd., SundaySky, TaKaDu, Trusteer and Waze

An electric battery based on boiled potatoes could provide a cheap source of electricity in the developing world, according to the technology transfer company of the Hebrew University of Jerusalem.

Yissum, the technology-transfer arm of the Hebrew University of Jerusalem, is exploring commercialization plans for a stochastic optimization algorithm that can be used to winnow down large compound libraries to a handful of molecules with the highest probability of possessing specific drug-like characteristics.